Atlas Trials

Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017

Clinical trial NCT00791752 · COMPLETED

Trial details

NCT number
NCT00791752
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2008-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.